Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Deferred Taxes (2016 - 2020)

Immucell (ICCC) has disclosed Deferred Taxes for 11 consecutive years, with $1.0 as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Deferred Taxes rose 100.01% year-over-year to $1.0, compared with a TTM value of -$14631.0 through Dec 2020, down 159.27%, and an annual FY2020 reading of -$14631.0, down 159.27% over the prior year.
  • Deferred Taxes was $1.0 for Q4 2020 at Immucell, up from -$14632.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $498822.0 in Q2 2018 and bottomed at -$293921.0 in Q4 2017.
  • Average Deferred Taxes over 5 years is $23547.1, with a median of -$2089.0 recorded in 2016.
  • The sharpest move saw Deferred Taxes crashed 1667.36% in 2017, then skyrocketed 775.38% in 2018.
  • Year by year, Deferred Taxes stood at $29378.0 in 2016, then tumbled by 1100.48% to -$293921.0 in 2017, then surged by 104.95% to $14545.0 in 2018, then plummeted by 148.9% to -$7112.0 in 2019, then surged by 100.01% to $1.0 in 2020.
  • Business Quant data shows Deferred Taxes for ICCC at $1.0 in Q4 2020, -$14632.0 in Q1 2020, and -$7112.0 in Q4 2019.